<DOC>
	<DOCNO>NCT02212249</DOCNO>
	<brief_summary>Ve-cadherin express endothelial cell . Systemic slerosis rare auto-immune disease endothelial dysfunction . This study evaluate level soluble VE-cadherin VE-cadherin antibody patient systemic slerosis .</brief_summary>
	<brief_title>Soluble VE-cadherin VE-cadherin Antibody Sclerodermic Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>group 1 : systemic sclerosis group 2 : raynaud primary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>soluble VE-cadherin</keyword>
	<keyword>antibody</keyword>
	<keyword>systemic slerosis</keyword>
</DOC>